Novella Clinical Partners with Academia on CV Clinical Trials Services
Novella Clinical and the Cardiovascular Research Foundation announced a preferred provider collaboration.
Novella Clinical, a Quintiles company, and the Cardiovascular Research Foundation announced a preferred provider collaboration that will offer a set of clinical trial services to developers of cardiovascular drugs and devices. Novella, is a full-service clinical research organization with specialization in cardiovascular medical device research, and the Cardiovascular Research Foundation Clinical Trials Center, the academic research organization of the Foundation, with its extensive group of cardiovascular physicians and core labs, will work together to provide sponsors comprehensive clinical research services-from preclinical to post-market studies.
Read the full release here.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Optimizing Phase III Oncology Trial Recruitment with Data-Driven Insights
February 3rd 2025A pharmaceutical company aimed to launch a Phase III clinical trial for a new oncology drug, focusing on efficient and effective patient recruitment across diverse regions. They evaluated patient populations by analyzing demographics, social determinants of health, and geography. Investigator profiling included practice details, affiliations, referral networks, and clinical trial experience. The final step involved selecting and extracting target lists for implementation.
